Photo from wikipedia
During the early phase of the coronavirus disease 2019 (COVID‐19), remdesivir was only approved for hospitalized patients. Our institution developed hospital‐based, outpatient infusion centers for selected hospitalized patients with COVID‐19… Click to show full abstract
During the early phase of the coronavirus disease 2019 (COVID‐19), remdesivir was only approved for hospitalized patients. Our institution developed hospital‐based, outpatient infusion centers for selected hospitalized patients with COVID‐19 who had clinical improvement to allow for early dismissal. The outcomes of patients who transitioned to complete remdesivir in the outpatient setting were examined.
Keywords:
treated remdesivir;
clinical outcomes;
remdesivir across;
remdesivir;
covid treated;
outcomes covid
Journal Title: Influenza and Other Respiratory Viruses
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Influenza and Other Respiratory Viruses
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!